Abstract:Radiotherapy of cancer has been traditionally considered as a local therapy without noticeable effects outside the irradiated fields. However, ionizing radiation exerts multiple biological effects on both malignant and stromal cells that account for a complex spectrum of mechanisms beyond simple termination of cancer cells. In the era of immunotherapy, interest in radiation-induced inflammation and cell death has considerably risen, since these mechanisms lead to profound changes in the systemic immune response against cancer antigens. Immunotherapies such as immunomodulatory monoclonal antibodies (anti-PD-1, anti-CTLA-4, anti-CD137, anti-OX40, anti-CD40, anti-TGFβ), TLR-agonists, and adoptive T-cell therapy have been synergistically combined with radiotherapy in mouse models. Importantly, radiation and immunotherapy combinations do not only act against the irradiated tumor but also against distant non-irradiated metastases (abscopal effects). A series of clinical trials are exploring the beneficial effects of radioimmunotherapy combinations. The concepts of crosspriming of tumor neoantigens and immunogenic cell death are key elements underlying this combination efficacy. Proinflamatory changes in the vasculature of the irradiated lesions and in the cellular composition of the leukocyte infiltrates in the tumor microenvironment contribute to raise or dampen cancer immunogenicity. It should be stressed that not all effects of radiotherapy favor antitumor immunity as there are counterbalancing mechanisms such as TGFβ, and VEGFs that inhibit the efficacy of the antitumor immune response, hence offering additional therapeutic targets to suppress. All in all, radiotherapy and immunotherapy are compatible and often synergistic approaches against cancer that jointly target irradiated and non-irradiated malignant lesions in the same patient.

Radiotherapy and Immunotherapy: a Beneficial Liaison?

The Intersection of Radiotherapy and Immunotherapy: Mechanisms and Clinical Implications.

Radiotherapy combined with immunotherapy: the dawn of cancer treatment

Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade

Radiotherapy and Immune Checkpoint Blockade: Potential Interactions and Future Directions.

Emerging evidence for adapting radiotherapy to immunotherapy

Synergistic effects of radiotherapy and targeted immunotherapy in improving tumor treatment efficacy: a review

Immune targets in the tumor microenvironment treated by radiotherapy

The Confluence of Radiotherapy and Immunotherapy.

Immune modulatory roles of radioimmunotherapy: biological principles and clinical prospects

Challenges in the combination of radiotherapy and immunotherapy for breast cancer

Immune mechanisms mediating abscopal effects in radioimmunotherapy

Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality

Abscopal effect: from a rare phenomenon to a new frontier in cancer therapy

Immunomodulation by radiotherapy in tumour control and normal tissue toxicity

Combination of radiotherapy and immunotherapy in duality with the protumoral action of radiation

Radiation therapy and the innate immune response: Clinical implications for immunotherapy approaches

Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy

Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions

Research Advances in Radiotherapy Combined with Immunotherapy for Cancer

Is an immune-oriented use of radiation therapy possible? An increasingly open question under the spotlight of immunotherapy